Abstract
Two human antidextran sera were each fractionated into two populations of antibody by specific absorption of the antidextran on an insoluble dextran (sephadex), washing away non-specific protein, eluting the first fraction of antibody with isomaltose or isomaltotriose, and the second fraction with isomaltohexaose. The differences in behavior of the purified antibody fractions alone, or reconstituted in serum, in quantitative inhibition studies with the isomaltose series of oligosaccharides, or in quantitative precipitin studies with NRC dextrans of graded molecular weight, could be ascribed to differences in the sizes of their combining sites. It was shown that the antibody fractions eluted with isomaltose or isomaltotriose were made up largely of antibodies inhibited readily by the smaller oligosaccharides and therefore having a higher proportion of molecules with smaller-sized combining sites; whereas those fractions eluted with isomaltohexaose contained primarily antibodies readily inhibitable only with the larger oligosaccharides, and hence were considered to have a higher proportion of larger-sized combining sites. The purified antibody fractions were shown to be only fast gamma globulin,—to possess the same mobility in immunoelectrophoresis; in addition the antibody fractions from one individual in double diffusion in agar gave lines which fused with one another, with gamma globulin Fr. II, and with a purified antidextran solution containing the entire population of antidextran antibodies. Evidence was also presented which indicated little or no change in the populations of antibody molecules produced in these two individuals for a period as long as 10 years following immunization. It is felt that these data offer substantial support for the hypothesis that the antidextran produced in a single individual consists of a heterogeneous population of antibody molecules with antibody-combining sites of various sizes.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALLEN P. Z., KABAT E. A. Persistence of circulating antibodies in human subjects immunized with dextran, levan and blood group substances. J Immunol. 1958 Jun;80(6):495–500. [PubMed] [Google Scholar]
- EDELMAN G. M., HEREMANS J. F., HEREMANS M. T., KUNKEL H. G. Immunological studies of human gamma-globulin. Relation of the precipitin lines of whole gamma-globulin to those of the fragments produced by papain. J Exp Med. 1960 Jul 1;112:203–223. doi: 10.1084/jem.112.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GOODMAN J. W., KABAT E. A. Immunochemical studies on cross-reactions of antipneumococcal sera. III. The effect of variation in molecular weight on the cross-reactivity of dextran with type II antipneumococcal serum. J Immunol. 1960 Oct;85:342–346. [PubMed] [Google Scholar]
- HALBERT S. P., SWICK L., SONN C. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics. J Exp Med. 1955 May 1;101(5):557–576. doi: 10.1084/jem.101.5.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HEREMANS J. F. Immunochemical studies on protein pathology. The immunoglobulin concept. Clin Chim Acta. 1959 Sep;4:639–646. doi: 10.1016/0009-8981(59)90004-x. [DOI] [PubMed] [Google Scholar]
- KABAT E. A., BERG D. Dextran; an antigen in man. J Immunol. 1953 Jun;70(6):514–532. [PubMed] [Google Scholar]
- KABAT E. A., BEZER A. E. The effect of variation in molecular weight on the antigenicity of dextran in man. Arch Biochem Biophys. 1958 Dec;78(2):306–318. doi: 10.1016/0003-9861(58)90354-0. [DOI] [PubMed] [Google Scholar]
- KABAT E. A. Heterogeneity in extent of the combining regions of human antidextran. J Immunol. 1956 Dec;77(6):377–385. [PubMed] [Google Scholar]
- KABAT E. A., SCHIFFMAN G. Immunochemical studies on blood groups. 28. Further studies on the oligosaccharide determinats of blood group B and BP1 specificity. J Immunol. 1962 Jun;88:782–787. [PubMed] [Google Scholar]
- KABAT E. A. The upper limit for the size of the human antidextran combining site. J Immunol. 1960 Jan;84:82–85. [PubMed] [Google Scholar]
- MAURER P. H. Dextran, an antigen in man. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):879–884. doi: 10.3181/00379727-83-20521. [DOI] [PubMed] [Google Scholar]
- McDUFFIE F. C., KABAT E. A., ALLEN P. Z., WILLIAMS C. A., Jr An immuno-chemical study of the relationship of human blood group isoantibodies to gamma1- & gamma2-globulins. J Immunol. 1958 Jul;81(1):48–64. [PubMed] [Google Scholar]
- TURVEY J. R., WHELAN W. J. Preparation and characterization of the isomaltodextrins. Biochem J. 1957 Sep;67(1):49–52. doi: 10.1042/bj0670049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILLIAMS C. A., Jr, GRABAR P. Immunoelectrophoretic studies on serum proteins. I. The antigens of human serum. J Immunol. 1955 Feb;74(2):158–168. [PubMed] [Google Scholar]
- WILSON M. W., PRINGLE B. H. Interpretation of the Ouchterlony precipitin test. J Immunol. 1955 Dec;75(6):460–469. [PubMed] [Google Scholar]